dibenz(b,f)(1,4)oxazepine-10(11h)-carboxylic acid, 8-chloro-, 2-acetylhydrazide has been researched along with celecoxib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguado, A; Alonso, MJ; Avendaño, MS; Beltrán, LM; Briones, AM; Cachofeiro, MV; García-Puig, J; González-Amor, M; Guillem-Llobat, P; Martínez-Revelles, S; Palacios, R; Salaices, M; Simões, MR; Vassallo, DV; Vila, L | 1 |
1 other study(ies) available for dibenz(b,f)(1,4)oxazepine-10(11h)-carboxylic acid, 8-chloro-, 2-acetylhydrazide and celecoxib
| Article | Year |
|---|---|
Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension.
Topics: Animals; Celecoxib; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; Dinoprostone; Dose-Response Relationship, Drug; Humans; Hypertension; Male; Mice; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Prostaglandin E, EP1 Subtype; Structure-Activity Relationship; Vascular Stiffness | 2016 |